CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 139 filers reported holding CARA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296 | -40.6% | 176 | 0.0% | 0.00% | – |
| Q2 2023 | $498 | -42.4% | 176 | 0.0% | 0.00% | – |
| Q1 2023 | $864 | -66.3% | 176 | -26.4% | 0.00% | -100.0% |
| Q4 2022 | $2,567 | +28.4% | 239 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 239 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | -33.3% | 239 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | -25.0% | 239 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | +33.3% | 239 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,000 | -40.0% | 239 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $5,000 | +66.7% | 239 | +9.1% | 0.00% | +50.0% |
| Q4 2020 | $3,000 | 0.0% | 219 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $3,000 | – | 219 | +1360.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 15 | -96.0% | 0.00% | -100.0% |
| Q3 2019 | $7,000 | -22.2% | 375 | -8.3% | 0.01% | -16.7% |
| Q2 2019 | $9,000 | +12.5% | 409 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $8,000 | -20.0% | 409 | -3.3% | 0.01% | +20.0% |
| Q3 2018 | $10,000 | – | 423 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |